Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Progetto di fotomedicina 14: PBMT per il miglioramento delle prestazioni in SOF (SOF)

18 maggio 2026 aggiornato da: Musculoskeletal Injury Rehabilitation Research for Operational Readiness

Valutazione dell'impatto dell'applicazione della fotobiomodulazione post-esercizio su prestazioni, recupero e stato comportamentale in una popolazione di operatori speciali addestrati

Le forze per le operazioni speciali (SOF) si addestrano continuamente per mantenere le massime prestazioni. Pertanto, sono quasi sempre in uno stato di recupero e necessitano di terapie non invasive per affrontare il carico di lavoro gravoso. La terapia di fotobiomodulazione (PBMT) è un trattamento non invasivo in cui un laser a basso livello viene applicato al corpo per migliorare la guarigione, il recupero e le prestazioni. La riabilitazione e il ricondizionamento rapido dell'ottimizzazione tattica umana dell'esercito (THOR3) fornisce una strada coerente per l'implementazione del PBMT come modalità. Gli studi sugli atleti hanno dimostrato benefici in termini di prestazioni e recupero con l'applicazione focale pre e post allenamento del PBMT. Sebbene ci siano meno prove sui potenziali effetti cognitivi/comportamentali di un’applicazione sistematica del PBMT, è stato riscontrato che anche l’affaticamento auto-riferito è significativamente inferiore nei gruppi con applicazione focale del PBMT rispetto al placebo. Inoltre, la ricerca PBMT su atleti tattici militari sani è limitata. Il PBMT può essere uno strumento promettente per migliorare le prestazioni fisiche accelerando il recupero muscoloscheletrico e psicologico nella popolazione SOF. I ricercatori mirano a studiare gli effetti fisiologici e comportamentali dell'applicazione PBMT post-esercizio sulle prestazioni degli operatori SOF.

L'intento: I ricercatori propongono di condurre uno studio di controllo randomizzato in singolo cieco con controllo fittizio per studiare l'efficacia della fornitura di PBMT post allenamento fisico in una popolazione SOF.

Gli obiettivi specifici di questo studio sono:

  1. Analizzare e descrivere gli eventuali effetti fisiologici dell'applicazione PBMT post-esercizio negli operatori delle forze speciali sottoposti ad addestramento condotto da allenatori.
  2. Analizzare e descrivere gli eventuali effetti comportamentali dell'applicazione PBMT post-esercizio negli operatori delle forze speciali sottoposti ad addestramento condotto da allenatori.
  3. Valutare l'utilità clinica complessiva del PBMT focale dopo l'allenamento fisico in una popolazione di atleti tattici SOF dell'esercito americano.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

29

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Stati Uniti
    • Washington
      • Joint Base Lewis McChord, Washington, Stati Uniti, 98433
        • Joint Base Lewis-McChord

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Sì

Descrizione

Criterio di inclusione:

  • Personale delle forze speciali in servizio attivo (serie 18)
  • In grado di leggere e comprendere la lingua inglese ai fini del consenso
  • In grado di impegnarsi nell'intervento e nel follow-up dello studio
  • In grado di partecipare alla formazione per coach THOR3, senza restrizioni

Criteri di esclusione:

  • Obesi (grasso corporeo > 25%)
  • Malattia cardiovascolare
  • Uso di farmaci selezionati (ad esempio statine, diuretici, agenti ipertensivi)
  • Femmina
  • Tatuaggio nell'area da trattare (regione del corpo)
  • Diagnosi con porfiria (allergia indotta dalla luce) o eczema fotosensibile
  • Uso attuale di farmaci associati alla sensibilità al calore o alla luce (ad es. amiodarone, clorpromazina, doxiciclina, idroclorotiazide, acido nalidixico, naprossene, piroxicam, tetraciclina, tioridazina, voriconazolo)
  • Uso di pacemaker/malattia cardiaca sottostante
  • Diagnosi di malattie autoimmuni
  • Albinismo
  • Neuropatia periferica

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore fittizio: PBMT fasullo
L'inclusione del PBMT fittizio garantirà che tutte le procedure di trattamento dei partecipanti rimangano le stesse, ad eccezione dell'emissione di fotoni (trattamento attivo), consentendo così di attribuire il contributo di eventuali differenze tra i gruppi all'uso del PBMT.
Dispositivo: Allenamento THOR3 + PBMT fittizio
Il PBMT simulato sarà fornito da un membro addestrato del team di studio. Il PBMT simulato verrà erogato nello stesso modo indicato per il processo PBMT sopra, ma il dispositivo rimarrà in modalità standby (ovvero, la modalità di trattamento non sarà attivata). Poiché la luce infrarossa è invisibile a occhio nudo, l'unica differenza visibile tra la modalità trattamento e quella standby è la presenza di alcune minuscole luci color ambra (queste luci sono accese durante la modalità trattamento).
Altri nomi:
  • Allenamento THOR3 + placebo
Comparatore attivo: Photobiomodulation Treatment (PBMT)
PBMT will be delivered at 40 watts (W). PBMT will be applied to the quadriceps area. A study team member will use the quadriceps measurements of the treatment area to calculate the PBMT treatment time (approximately 5-20 minutes) and specified J/cm2. PBMT treatment will be provided 3 times per week, for 3 weeks.
Dispositivo: THOR3 training + Photobiomodulation Therapy (PBMT)

PBMT will be delivered at 40W (depending on participant skin pigmentation). PBMT will be applied to the quadriceps area. A study team member will use the quadriceps measurements of the treatment area to calculate the PBMT treatment time (approximately 5-20 minutes) and specified J/cm2. PBMT treatment will be provided 3 times per week, for 3 weeks.

PBMT will be delivered by a trained study team member using the LightForce® XLi 40W device with the Smart Hand Piece technology, which has a built-in accelerometer in the hand piece that controls the speed of light delivery to the treatment area. The trained team members will use the Smart Hand Piece technology, which assesses the operator's speed and provides real-time visual and sensory feedback calibrated to shut-off when moving too slowly and warns the operator when moving too quickly by vibrating. Treatment is delivered through a flexible optical fiber threaded through the hand piece, which contains a rolling glass massage ball.

Altri nomi:
  • Terapia laser a basso livello (LLLT)
  • LightForce®XLi

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Countermovement Jump (CMJ) Initial Baseline: Concentric Impulse
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Assesses dynamic strength performance, including concentric impulse via force plates and analysis software.
Collected prior to treatment starting at time of enrollment.
Countermovement Jump (CMJ) Initial Baseline: Movement Start to Peak Power.
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Assesses dynamic strength performance, including Movement start to peak power. via force plates and analysis software.
Collected prior to treatment starting at time of enrollment.
Countermovement Jump (CMJ) Initial Baseline: Reactive Strength Index-modified (RSImod)
Lasso di tempo: Collected prior to treatment starting at time of enrollment.

Assesses dynamic strength performance, including Reactive Strength Index-modified (RSImod) via force plates and analysis software. Reactive Strength Index-modified (RSImod) reflects the efficiency of force production during a countermovement jump. It is calculated as jump height divided by time to take-off. Higher values indicate better explosive performance and lower neuromuscular fatigue, whereas lower values indicate reduced efficiency or increased fatigue. The index ranges from 0 upward with no theoretical maximum; therefore, interpretation should rely on normative ranges or athlete-specific baselines.

Reference categories:

Lower performers (L): ~0.20-0.30

Moderate performers (M): ~0.30-0.45

Upper performers (U): ~0.45-0.70+
Collected prior to treatment starting at time of enrollment.
Countermovement Jump (CMJ) Initial Baseline: Time to Take-Off
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Assesses dynamic strength performance, including Time to Take-Off via force plates and analysis software.
Collected prior to treatment starting at time of enrollment.
Countermovement Jump (CMJ) Week 1 Follow-up: Concentric Impulse
Lasso di tempo: Collected at the end of week 1 prior to coach-led training.
Assesses dynamic strength performance, including concentric impulse via force plates and analysis software.
Collected at the end of week 1 prior to coach-led training.
Countermovement Jump (CMJ) Week 1 Follow-up: Movement Start to Peak Power
Lasso di tempo: Collected at the end of week 1 prior to coach-led training.
Assesses dynamic strength performance, including Movement Start to peak Power via force plates and analysis software.
Collected at the end of week 1 prior to coach-led training.
Countermovement Jump (CMJ) Week 1 Follow-up: Reactive Strength Index-modified (RSImod)
Lasso di tempo: Collected at the end of week 1 prior to coach-led training.

Assesses dynamic strength performance, including Reactive Strength Index-modified (RSImod) via force plates and analysis software. Reactive Strength Index-modified (RSImod) reflects the efficiency of force production during a countermovement jump. It is calculated as jump height divided by time to take-off. Higher values indicate better explosive performance and lower neuromuscular fatigue, whereas lower values indicate reduced efficiency or increased fatigue. The index ranges from 0 upward with no theoretical maximum; therefore, interpretation should rely on normative ranges or athlete-specific baselines.

Reference categories:

Lower performers (L): ~0.20-0.30

Moderate performers (M): ~0.30-0.45

Upper performers (U): ~0.45-0.70+
Collected at the end of week 1 prior to coach-led training.
Countermovement Jump (CMJ) Week 1 Follow-up: Time to Take-Off
Lasso di tempo: Collected at the end of week 1 prior to coach-led training.
Assesses dynamic strength performance, including Time to Take-Off via force plates and analysis software.
Collected at the end of week 1 prior to coach-led training.
Countermovement Jump (CMJ) Week 2 Follow-up: Concentric Impulse
Lasso di tempo: Collected at the end of week 2 prior to coach-led training.
Assesses dynamic strength performance, including concentric impulse via force plates and analysis software.
Collected at the end of week 2 prior to coach-led training.
Countermovement Jump (CMJ) Week 2 Follow-up: Movement Start to Peak Power
Lasso di tempo: Collected at the end of week 2 prior to coach-led training.
Assesses dynamic strength performance, including peak force production via force plates and analysis software.
Collected at the end of week 2 prior to coach-led training.
Countermovement Jump (CMJ) Week 2 Follow-up: Reactive Strength Index-modified (RSImod)
Lasso di tempo: Collected at the end of week 2 prior to coach-led training.

Assesses dynamic strength performance, including Reactive Strength Index-modified (RSImod) via force plates and analysis software. Reactive Strength Index-modified (RSImod) reflects the efficiency of force production during a countermovement jump. It is calculated as jump height divided by time to take-off. Higher values indicate better explosive performance and lower neuromuscular fatigue, whereas lower values indicate reduced efficiency or increased fatigue. The index ranges from 0 upward with no theoretical maximum; therefore, interpretation should rely on normative ranges or athlete-specific baselines.

Reference categories:

Lower performers (L): ~0.20-0.30

Moderate performers (M): ~0.30-0.45

Upper performers (U): ~0.45-0.70+
Collected at the end of week 2 prior to coach-led training.
Countermovement Jump (CMJ) Week 2 Follow-up: Time to Take-Off
Lasso di tempo: Collected at the end of week 2 prior to coach-led training.
Assesses dynamic strength performance, including Time to Take-Off via force plates and analysis software.
Collected at the end of week 2 prior to coach-led training.
Countermovement Jump (CMJ) Week 3 Follow-up: Concentric Impulse
Lasso di tempo: Collected at the end of week 3 prior to coach-led training.
Assesses dynamic strength performance, including concentric impulse via force plates and analysis software.
Collected at the end of week 3 prior to coach-led training.
Countermovement Jump (CMJ) Week 3 Follow-up: Movement Start to Peak Power
Lasso di tempo: Collected at the end of week 3 prior to coach-led training.
Assesses dynamic strength performance, including peak force production via force plates and analysis software.
Collected at the end of week 3 prior to coach-led training.
Countermovement Jump (CMJ) Week 3 Follow-up: Reactive Strength Index-modified (RSImod)
Lasso di tempo: Collected at the end of week 3 prior to coach-led training.

Assesses dynamic strength performance, including Reactive Strength Index-modified (RSImod) via force plates and analysis software. Reactive Strength Index-modified (RSImod) reflects the efficiency of force production during a countermovement jump. It is calculated as jump height divided by time to take-off. Higher values indicate better explosive performance and lower neuromuscular fatigue, whereas lower values indicate reduced efficiency or increased fatigue. The index ranges from 0 upward with no theoretical maximum; therefore, interpretation should rely on normative ranges or athlete-specific baselines.

Reference categories:

Lower performers (L): ~0.20-0.30

Moderate performers (M): ~0.30-0.45

Upper performers (U): ~0.45-0.70+
Collected at the end of week 3 prior to coach-led training.
Countermovement Jump (CMJ) Week 3 Follow-up: Time to Take-Off
Lasso di tempo: Collected at the end of week 3 prior to coach-led training.
Assesses dynamic strength performance, including Time to Take-Off via force plates and analysis software.
Collected at the end of week 3 prior to coach-led training.
Isometric Quadriceps Strength Testing Initial Baseline: Peak Torque
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Measuring isolated strength (Peak Torque).
Collected prior to treatment starting at time of enrollment.
Isometric Hamstrings Strength Testing Initial Baseline: Peak Torque.
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Measuring isolated strength (Peak Torque).
Collected prior to treatment starting at time of enrollment.
Isokinetic Quadriceps Strength Testing Initial Baseline: Peak Torque
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Measuring isolated strength (Peak Torque).
Collected prior to treatment starting at time of enrollment.
Isokinetic Hamstrings Strength Testing Initial Baseline: Peak Torque
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Measuring isolated strength (Peak Torque).
Collected prior to treatment starting at time of enrollment.
Isometric Quadriceps Strength Testing 3-week Follow-up: Peak Torque
Lasso di tempo: Collected at the 3-week follow-up session prior to coach-led training.
Measuring isolated strength (Peak Torque).
Collected at the 3-week follow-up session prior to coach-led training.
Isometric Hamstrings Strength Testing 3-week Follow-up: Peak Torque.
Lasso di tempo: Collected at the 3-week follow-up session prior to coach-led training.
Measuring isolated strength (Peak Torque).
Collected at the 3-week follow-up session prior to coach-led training.
Isokinetic Quadriceps Strength Testing 3-week Follow-up: Peak Torque
Lasso di tempo: Collected at the 3-week follow-up session prior to coach-led training.
Measuring isolated strength (Peak Torque).
Collected at the 3-week follow-up session prior to coach-led training.
Isokinetic Hamstrings Strength Testing 3-week Follow-up: Peak Torque
Lasso di tempo: Collected at the 3-week follow-up session prior to coach-led training.
Measuring isolated strength (Peak Torque).
Collected at the 3-week follow-up session prior to coach-led training.
Defense and Veteran's Pain Rating Scale (DVPRS) Initial Baseline
Lasso di tempo: Self-reported at baseline
Captures subjective pain rating on a 0 - 10 scale (minimum - maximum; 0 = no pain, 10 = severe pain). Higher scores equal worse outcomes.
Self-reported at baseline
Defense and Veteran's Pain Rating Scale (DVPRS) Daily Reports
Lasso di tempo: Self-reported, daily after baseline through study completion after 3 weeks.
Captures subjective pain rating on a 0 - 10 scale (minimum - maximum; 0 = no pain, 10 = severe pain). Higher scores equals worse outcomes. Calculation for this timepoint was dervied from averaging all daily pain scores into an aggregate value.
Self-reported, daily after baseline through study completion after 3 weeks.
Visual Analog Scale (VAS) Initial Baseline
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Measures delayed onset muscle soreness. Respondents mark on a 10 centimeter line their current level of muscle soreness. The left end of the line represents "I feel no soreness in my muscles" and the right end represents "My muscles feel so sore, I don't want to move them." Scores range from 0-100, with higher scores equaling worse outcomes.
Collected prior to treatment starting at time of enrollment.
Visual Analog Scale (VAS) Week 1 Follow-up
Lasso di tempo: Collected at the end of week 1 after coach-led training and laser treatment.
Measures delayed onset muscle soreness. Respondents mark on a 10 centimeter line their current level of muscle soreness. The left end of the line represents "I feel no soreness in my muscles" and the right end represents "My muscles feel so sore, I don't want to move them." Scores range from 0-100, with higher scores equaling worse outcomes.
Collected at the end of week 1 after coach-led training and laser treatment.
Visual Analog Scale (VAS) Week 2 Follow-up
Lasso di tempo: Collected at the end of week 2 after coach-led training and laser treatment.
Measures delayed onset muscle soreness. Respondents mark on a 10 centimeter line their current level of muscle soreness. The left end of the line represents "I feel no soreness in my muscles" and the right end represents "My muscles feel so sore, I don't want to move them." Scores range from 0-100, with higher scores equaling worse outcomes.
Collected at the end of week 2 after coach-led training and laser treatment.
Visual Analog Scale (VAS) Week 3 Follow-up
Lasso di tempo: Collected at the end of week 3 after coach-led training and laser treatment.
Measures delayed onset muscle soreness. Respondents mark on a 10 centimeter line their current level of muscle soreness. The left end of the line represents "I feel no soreness in my muscles" and the right end represents "My muscles feel so sore, I don't want to move them." Scores range from 0-100, with higher scores equaling worse outcomes.
Collected at the end of week 3 after coach-led training and laser treatment.
Borg Modified Rating of Perceived Exertion (RPE) Initial Baseline
Lasso di tempo: Collected prior to treatment starting at time of enrollment
Quantifying perceived exertion on 0-10 scale. Higher scores indicate worse outcomes.
Collected prior to treatment starting at time of enrollment
Borg Modified Rating of Perceived Exertion (RPE) 3-week Follow-up
Lasso di tempo: Collected at the 3-week follow-up session after coach-led training and laser treatment.
Quantifying perceived exertion on 0-10 scale. Higher scores indicate worse outcomes.
Collected at the 3-week follow-up session after coach-led training and laser treatment.
Elloumi Fatigue Scale Initial Baseline
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Behavioral health rating of fatigue. The short questionnaire of fatigue uses eight questions that highlight perception of training difficulty, sleep, leg discomfort, infection/colds, concentration, work efficacy, anxiety and overall stress. Each question is rated by the respondent on a 7-point scale: 1 point (not at all) to 7 points (very much). The summed total score of the 8 questions allows for a total score of fatigue (TSF). Total score of fatigue ranges from 8 points (not at all fatigued) to 56 points (very much fatigued).
Collected prior to treatment starting at time of enrollment.
Elloumi Fatigue Scale 3-week Follow-up
Lasso di tempo: Collected at the 3-week follow-up session after coach-led training and laser treatment.
Behavioral health rating of fatigue. The short questionnaire of fatigue uses eight questions that highlight perception of training difficulty, sleep, leg discomfort, infection/colds, concentration, work efficacy, anxiety and overall stress. Each question is rated by the respondent on a 7-point scale: 1 point (not at all) to 7 points (very much). The summed total score of the 8 questions allows for a total score of fatigue (TSF). Total score of fatigue ranges from 8 points (not at all fatigued) to 56 points (very much fatigued).
Collected at the 3-week follow-up session after coach-led training and laser treatment.
Quick Physical Activity Rating Scale (QPAR)
Lasso di tempo: Collected prior to treatment starting at time of enrollment.
Higher scores indicate better outcome. Scaled rating of various types of physical activity participation. Respondent reporting quantifies the overall amount of physical activity that the respondent regularly engages in. Activities are weighted in intensity that ranges from 1 (light) to 3 (heavy). Activity weekly frequency reported as never (0 days), seldom (1-2 days), sometime (3-4 days), and often (5-7 days). Activity duration collected as less than one hour per day, 1-2 hours per day, and more than two hours per day. Intensity (1-3), frequency (0-3) and duration (1-3) scores are multiplied and provide a physical activity score that may range from 0 - 153 points, 0 being very low physical activity and 153 representing very high physical activity.
Collected prior to treatment starting at time of enrollment.
Oura Ring Sleep Data: Sleep Metrics - Sleep Duration
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including duration of sleep. Calculation for this measure was dervied from averaging all daily sleep scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Sleep Metrics - Time in Bed
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including time spent in bed. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Sleep Metrics - Light Sleep Length
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including duration of light sleep stage. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Sleep Metrics - Rapid Eye Movement (REM) Sleep Length
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including duration of REM sleep stage. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Sleep Metrics - Deep Sleep Length
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including duration of deep sleep stage (seconds). Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Sleep Metrics - Sleep Latency
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including sleep latency (time taken to fall asleep in seconds). Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Sleep Metrics - Sleep Efficiency Percentage
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including sleep efficiency percentage (time spent in bed asleep). Higher percentages are better. 0-100. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Sleep Metrics - Sleep Quality Score
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of sleep, including sleep quality score. Scores range from 0-100 with higher scores being better outcomes. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Readiness Trends - Body Temperature Changes
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure changes in body temperature. Oura calculates body-temperature readiness by measuring average skin temperature during sleep, comparing it to long-term baseline, and reporting the difference as a positive or negative deviation. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Data: Readiness Trends - Daily Heart Rate
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of physical readiness trends, including changes in heart rate. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Readiness Trends - Heart Rate Variability (HRV)
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of physical readiness trends, including HRV - a measure of the fluctuation in the time intervals between adjacent heartbeats. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Readiness Trends - Respiration Rate
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of physical readiness trends, including respiratory rate. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Readiness Trends - Blood Oxygen Saturation
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of physical readiness trends, including blood oxygen saturation. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Readiness Trends - Sleep Balance
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of physical readiness trends, including sleep balance- a measure of how consistent nightly total sleep duration is compared to baseline, reported on a 0-100 scale where higher means sleep length is closely matched night-to-night. Scores near 100 indicate very stable sleep duration that supports recovery; 60-80 indicates moderate variability that may mildly reduce readiness; scores below ~60 reflect inconsistent sleep duration likely to lower Readiness. Higher scores are better outcomes. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring Sleep Data: Readiness Trends - Readiness Score
Lasso di tempo: Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.
Oura Ring will continuously measure aspects of physical readiness trends, including readiness score. The score ranges from 0-100, higher scores indicate better outcomes. Calculation for this measure was dervied from averaging all daily scores into an aggregate value.
Oura data is collected from daily wear of ring from date of randomization through study completion after 3 weeks.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Body Measurements: Body Composition (% Body Fat)
Lasso di tempo: Measured prior to treatment starting at time of enrollment.
Biometrics
Measured prior to treatment starting at time of enrollment.
Body Measurements: Height (Inches)
Lasso di tempo: Measured prior to treatment starting at time of enrollment.
Biometrics
Measured prior to treatment starting at time of enrollment.
Body Measurements: Weight (Lbs)
Lasso di tempo: Measured prior to treatment starting at time of enrollment.
Biometrics
Measured prior to treatment starting at time of enrollment.
Body Measurements: C1 - Proximal Thigh Circumference (cm)
Lasso di tempo: Measured prior to treatment starting at time of enrollment.
Biometrics - used to calculate PBMT dosage
Measured prior to treatment starting at time of enrollment.
Body Measurements: C2 - Distal Thigh Circumference (cm)
Lasso di tempo: Measured prior to treatment starting at time of enrollment.
Biometrics - used to calculate PBMT dosage
Measured prior to treatment starting at time of enrollment.
Body Measurements: L1 - Length of Thigh (cm)
Lasso di tempo: Measured prior to treatment starting at time of enrollment.
Biometrics - used to calculate PBMT dosage
Measured prior to treatment starting at time of enrollment.

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Misure del corpo: Altezza (cm)
Lasso di tempo: Misurato prima del trattamento che inizia al momento dell'arruolamento.
Biometrica
Misurato prima del trattamento che inizia al momento dell'arruolamento.
Misure del corpo: peso (kg/libbre)
Lasso di tempo: Misurato prima del trattamento che inizia al momento dell'arruolamento.
Biometrica
Misurato prima del trattamento che inizia al momento dell'arruolamento.
Misure corporee: composizione corporea (% di grasso corporeo)
Lasso di tempo: Misurato prima del trattamento che inizia al momento dell'arruolamento.
Biometrica
Misurato prima del trattamento che inizia al momento dell'arruolamento.
Misure del corpo: C1 - circonferenza prossimale della coscia (cm)
Lasso di tempo: Misurato prima del trattamento che inizia al momento dell'arruolamento.
Biometria: utilizzata per calcolare il dosaggio PBMT
Misurato prima del trattamento che inizia al momento dell'arruolamento.
Misure del corpo: C2 - circonferenza distale della coscia (cm)
Lasso di tempo: Misurato prima del trattamento che inizia al momento dell'arruolamento.
Biometria: utilizzata per calcolare il dosaggio PBMT
Misurato prima del trattamento che inizia al momento dell'arruolamento.
Misure del corpo: L1 - lunghezza della coscia (cm)
Lasso di tempo: Misurato prima del trattamento che inizia al momento dell'arruolamento.
Biometria: utilizzata per calcolare il dosaggio PBMT
Misurato prima del trattamento che inizia al momento dell'arruolamento.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Musculoskeletal Injury Rehabilitation Research for Operational Readiness

Collaboratori

Uniformed Services University of the Health Sciences
The Geneva Foundation
1st Special Forces Group (Airborne), United States Army
United States Army Special Operations Command

Investigatori

  • Investigatore principale: Tanner Santarelli, DPT, 1st Special Forces Group Tactical Human Optimization, Rapid Rehabilitation and Reconditioning (THOR3)

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Collegamenti utili

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

23 gennaio 2025

Completamento primario (Effettivo)

2 marzo 2026

Completamento dello studio (Effettivo)

2 marzo 2026

Date di iscrizione allo studio

Primo inviato

13 marzo 2024

Primo inviato che soddisfa i criteri di controllo qualità

18 aprile 2024

Primo Inserito (Effettivo)

23 aprile 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • USUHS.2023-126

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

Il modulo di consenso iniziale (ICF) per questo studio di ricerca afferma che i dati di ricerca deidentificati saranno condivisi con MIRROR e USU e mantenuti a tempo indeterminato per un possibile utilizzo nella ricerca futura. Acconsentendo a partecipare a questo studio di ricerca, i partecipanti accettano di consentirci di conservare i loro dati di ricerca anonimizzati a tempo indeterminato per un possibile utilizzo in ricerche future.

Ai partecipanti non verrà data la possibilità di rinunciare alla conservazione dei propri dati di ricerca non identificati a tempo indeterminato per un possibile utilizzo futuro. L'ICF afferma: "Se non desideri che i tuoi dati deidentificati raccolti come parte di questo studio di ricerca vengano conservati per essere utilizzati in futuri studi di ricerca, non dovresti firmare questo modulo di consenso".

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA
  • ICF
  • CODICE_ANALITICO
  • RSI

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

Sì

prodotto fabbricato ed esportato dagli Stati Uniti

Sì

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Allenamento THOR3 + PBMT fittizio

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Dominican Republic

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

3
Sottoscrivi